These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 4001292)

  • 1. A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people.
    Hill BK; Balow EA; Bruininks RH
    Psychopharmacol Bull; 1985; 21(2):279-84. PubMed ID: 4001292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic medication of mentally retarded residents in community long-term care facilities.
    Buck JA; Sprague RL
    Am J Ment Retard; 1989 May; 93(6):618-23. PubMed ID: 2566316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotropic use in community residential care facilities: A prospective cohort study.
    Lakey SL; Gray SL; Sales AE; Sullivan J; Hedrick SC
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):227-35. PubMed ID: 17062323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychoactive drug use in public and community residential facilities for mentally retarded persons.
    Intagliata J; Rinck C
    Psychopharmacol Bull; 1985; 21(2):268-78. PubMed ID: 4001291
    [No Abstract]   [Full Text] [Related]  

  • 6. National survey of community residential facilities: a profile of facilities and residents in 1977.
    Bruininks RH; Hauber FA; Kudla MJ
    Am J Ment Defic; 1980 Mar; 84(5):470-8. PubMed ID: 7361824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individuals with mental retardation in residential facilities: findings from the 1987 National Medical Expenditure Survey.
    Cunningham PJ; Mueller CD
    Am J Ment Retard; 1991 Sep; 96(2):109-17. PubMed ID: 1930944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National census of residential facilities: a 1982 profile of facilities and residents.
    Hauber FA; Bruininks RH; Hill BK; Lakin KC; Scheerenberger RC; White CC
    Am J Ment Defic; 1984 Nov; 89(3):236-45. PubMed ID: 6517106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living among strangers: the needs and functioning of persons with schizophrenia residing in an assisted living facility.
    Cadena SV
    Issues Ment Health Nurs; 2006 Jan; 27(1):25-41. PubMed ID: 16352514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic drug use in intellectually disabled group-home residents with behavioural problems.
    Stolker JJ; Koedoot PJ; Heerdink ER; Leufkens HG; Nolen WA
    Pharmacopsychiatry; 2002 Jan; 35(1):19-23. PubMed ID: 11819154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental characteristics of residential facilities for mentally retarded persons in the United States.
    Rotegard LL; Hill BK; Bruininks RH
    Am J Ment Defic; 1983 Jul; 88(1):49-56. PubMed ID: 6614062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug use by mentally handicapped persons in institutions and family-replacing residential facilities].
    van Schrojenstein Lantman-de Valk HM; Kessels AG; Haveman MJ; Maaskant MA; Urlings HF; van den Akker M
    Ned Tijdschr Geneeskd; 1995 May; 139(21):1083-8. PubMed ID: 7783802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social integration of older persons with mental retardation in residential facilities.
    Anderson DJ; Lakin KC; Hill BK; Chen TH
    Am J Ment Retard; 1992 Mar; 96(5):488-501. PubMed ID: 1562307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Social support of mentally handicapped adults: effects of degree of handicap and type of residential facility].
    Meins W
    Psychiatr Prax; 1993 May; 20(3):106-8. PubMed ID: 8378480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of medication records and use of pharmacy resources in community residential care facilities.
    Gray SL; Odegard PS; Sales AE; Young HM; Sullivan JH; Hedrick SC
    Ann Pharmacother; 2006 May; 40(5):894-9. PubMed ID: 16638918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of size to resident and staff behavior in small community residences.
    Landesman-Dwyer S; Sackett GP; Kleinman JS
    Am J Ment Defic; 1980 Jul; 85(1):6-17. PubMed ID: 7446570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation.
    Sunder TR; McKee JR; Hammer AE; Vuongc A
    Curr Med Res Opin; 2006 Apr; 22(4):693-702. PubMed ID: 16684430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of psychotropic medication in mental retardation facilities.
    Tu JB
    J Clin Psychiatry; 1979 Mar; 40(3):125-8. PubMed ID: 33967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maladaptive behavior of mentally retarded individuals in residential facilities.
    Hill BK; Bruininks RH
    Am J Ment Defic; 1984 Jan; 88(4):380-7. PubMed ID: 6695959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychotropic medicines to patients with mental retardation].
    Bygdnes AM; Kristiansen A
    Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1028-30. PubMed ID: 17457386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.